臨床研究等提出・公開システム

Scientific Title	The establishment of diagnostic imaging technology for breast cancer with microwave imaging
Public Title	Microwave imaging for breast cancer

Contact for Scientific Queries	Name	Fujii Kimihito
	Affiliation	Aichi Medical University Hospital
	Address	1-1, Yazakokarimata, Nagakute-city, Aichi 480-1195, Japan
	Telephone	+81-561623311
	E-mail	kfujii@aichi-med-u.ac.jp
Contact for Public Queries	Name	Fujii Kimihito
	Affiliation	Aichi Medical University Hospital
	Address	1-1, Yazakokarimata, Nagakute-city, Aichi 480-1195, Japan
	Telephone	+81-561623311
	E-mail	kfujii@aichi-med-u.ac.jp

Recruitment status	Recruiting

Anticipated date of first enrollment		Oct. 17, 2023
Target sample size		50
Study Type		Interventional
Study Design	allocation	single arm study
	masking	open(masking not used)
	control	uncontrolled control
	assignment	single assignment
	purpose	diagnostic purpose
Key inclusion & exclusion criteria	Inclusion Criteria	Breast cancer patients whose tumor diameter is over 10 mm.
	Exclusion Criteria	Patients whose tumor diameter < 10mm
	Age Minimum	18age old over
	Age Maximum	No limit
	Gender	Female
Health Condition(s) or Problem(s) Studied		Breast cancer
Intervention(s)		1. Imaging examination of breast cancer using microwave imaging (MI) technique is indicated for operative patients. 2. Comparison analyses between magnetic resonance imaging (MRI) and MI of breast cancer is performed on the same patient. The factors of analyses incude the coordicate and brightness value of the breast cancer. 3. The samples including cancer tissue, fat and normal mammary gland are collected from the surgically removed specimen. And those samples are served for measuring electric canstant.
Health Condition(s) Keyword		Breasr cancer
Intervention(s) Keyword		Microwave imaging techinique for breast cancer
Health Condition(s) Code		D001943
Intervention(s) Code		D015674
Primary Outcome(s)		1. Mesurement of the deviation of the coodinate and brightness value produced with MRI and MI images of the breast cancer. 2. Assesment of the correlation between the human breast tisue including cancer and its electoric constant.

Secondary Sponsor

Secondary Sponsor

Name of Certified Review Board	Certified Clinical Research Review Board of Aichi Medical University Hospital
Address	1-1, Yazakokarimata, Nagakute-city, Aichi 480-1195, Japan, Aichi
Telephone	+81-561623311
E-Mail	amu_crb@aichi-med-u.ac.jp
Approval Status	Approval
Date of approval	Oct. 02, 2023

Plan to share IPD	No

Countries of Recruitment（Except Japan）	none